Bifiform, 40 pcs.

Enterococcus faecium and Bifidobacterium longum strains included in the drug are natural symbiotic bacteria that inhabit the gastrointestinal tract. The drug has a normalizing effect on the quantitative and qualitative composition of the intestinal microflora.

The action is conditioned by direct direct effect of ingredients of the preparation (high antagonistic activity in respect of pathogenic and conditionally pathogenic microorganisms) and indirect – stimulation of local intestinal immunity (activation of immunoglobulin A synthesis, induction of endogenous interferon synthesis).

Bifidobacterium longum has high survival rate in human intestine and high growth rate. Inclusion of Enterococcus faecium apathogenic enterococcus that normally colonizes small intestine allows to have a positive effect on condition and digestive functions of not only large but also small intestine, especially in case of fermentative dyspepsia and flatulence phenomena.

Indications

Active ingredient

Composition

How to take, the dosage

Indication

Dose and multiplicity of administration

Duration of administration*

Acute diarrhea

until stool normalization

1 capsule
4 times a day

until stool normalization

after stool normalization until symptoms disappear completely

1 capsule
3 times a day

14 days

2 capsules
2 times a day

14 days (from the first day of eradication therapy)

* The duration of administration may be adjusted upon the doctor’s recommendation. If necessary, the course of treatment may be repeated.

Interaction

Contraindications

Side effects

Overdose